Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.25 - $11.7 $124 - $5,838
-499 Reduced 4.17%
11,473 $3,000
Q2 2022

Aug 10, 2022

SELL
$0.3 - $1.31 $605 - $2,644
-2,019 Reduced 14.43%
11,972 $4,000
Q1 2022

May 13, 2022

SELL
$0.61 - $1.84 $2,302 - $6,946
-3,775 Reduced 21.25%
13,991 $19,000
Q4 2021

Feb 10, 2022

BUY
$1.16 - $2.74 $20,608 - $48,678
17,766 New
17,766 $21,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $11.3M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.